Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.
Vredenburgh JJ, Desjardins A, Herndon JE 2nd, Dowell JM, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Wagner M, Bigner DD, Friedman AH, Friedman HS.
Vredenburgh JJ, et al.
Clin Cancer Res. 2007 Feb 15;13(4):1253-9. doi: 10.1158/1078-0432.CCR-06-2309.
Clin Cancer Res. 2007.
PMID: 17317837
Clinical Trial.